[1] |
Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function[J]. Am J Med, 1964, 36(4):561-570. doi: 10.1016/0002-9343(64)90104-4.
doi: 10.1016/0002-9343(64)90104-4
|
[2] |
Fu R, Sutcliffe D, Zhao H, et al. Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways[J]. Mol Genet Metab, 2015, 114(1):55-61. doi: 10.1016/j.ymgme.2014.11.001.
doi: 10.1016/j.ymgme.2014. 11.001
|
[3] |
McCarthy GT, Green EM, Ogunbona O, et al. A population study of Lesch-Nyhan disease in the UK[J]. Dev Med Child Neurol, 2011, 53(1):34-39. doi: 10.1111/j.1469-8749.2010.03786.x.
doi: 10.1111/j.1469-8749.2010.03786.x
pmid: 21126241
|
[4] |
Jolly DJ, Okayama H, Berg P, et al. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase[J]. Proc Natl Acad Sci U S A, 1983, 80(2):477-481. doi: 10.1073/pnas.80.2.477.
doi: 10.1073/pnas.80.2.477
pmid: 6300847
|
[5] |
Keebaugh AC, Sullivan RT, Thomas JW. Gene duplication and inactivation in the HPRT gene family[J]. Genomics, 2007, 89(1):134-142. doi: 10.1016/j.ygeno.2006.07.003.
doi: 10.1016/j.ygeno.2006.07.003
pmid: 16928426
|
[6] |
Inokuchi T, Moriwaki Y, Takahashi S, et al. Identification of a new point mutation in hypoxanthine phosphoribosyl transferase responsible for hyperuricemia in a female patient[J]. Metabolism, 2004, 53(11):1500-1502. doi: 10.1016/j.metabol.2004.04.016.
doi: 10.1016/j.metabol.2004.04.016
|
[7] |
Bell S, McCarty V, Peng H, et al. Lesch-Nyhan disease causes impaired energy metabolism and reduced developmental potential in midbrain dopaminergic cells[J]. Stem Cell Reports, 2021, 16(7):1749-1762. doi: 10.1016/j.stemcr.2021.06.003.
doi: 10.1016/j.stemcr.2021.06.003
|
[8] |
Harris JC. Lesch-Nyhan syndrome and its variants: examining the behavioral and neurocognitive phenotype[J]. Curr Opin Psychiatry, 2018, 31(2):96-102. doi: 10.1097/YCO.0000000000000388.
doi: 10.1097/YCO.0000000000000388
|
[9] |
Rylance HJ, Wallace RC, Nuki G. Hypoxanthine-guanine phosphoribosyl transferase: assay using high performance liquid chromatography[J]. Clin Chim Acta, 1982, 121(2):159-165. doi: 10.1016/0009-8981(82)90054-7.
doi: 10.1016/0009-8981(82)90054-7
pmid: 7094337
|
[10] |
Halley D, Heukels-Dully MJ. Rapid prenatal diagnosis of the Lesch-Nyhan syndrome[J]. J Med Genet, 1977, 14(2):100-102. doi: 10.1136/jmg.14.2.100.
doi: 10.1136/jmg.14.2.100
pmid: 856956
|
[11] |
Mizuno TI, Yugari Y. Letter: Self mutilation in Lesch-Nyhan syndrome[J]. Lancet, 1974, 1(7860):761. doi: 10.1016/s0140-6736(74)92990-0.
doi: 10.1016/s0140-6736(74)92990-0
|
[12] |
Frith CD, Johnston EC, Joseph MH, et al. Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome[J]. J Neurol Neurosurg Psychiatry, 1976, 39(7):656-662. doi: 10.1136/jnnp.39.7.656.
doi: 10.1136/jnnp.39.7.656
|
[13] |
Goldstein M, Anderson LT, Reuben R, et al. Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation[J]. Lancet, 1985, 1(8424):338-339. doi: 10.1016/s0140-6736(85)91107-9.
doi: 10.1016/s0140-6736(85)91107-9
pmid: 2857386
|
[14] |
Sabus A, Feinstein J, Romani P, et al. Management of Self-injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview[J]. Pharmacotherapy, 2019, 39(6):645-664. doi: 10.1002/phar.2238.
doi: 10.1002/phar.2238
|
[15] |
Colley AF, Leversha MA, Voullaire LE, et al. Five cases demonstrating the distinctive behavioural features of chromosome deletion 17(p11.2 p11.2) (Smith-Magenis syndrome)[J]. J Paediatr Child Health, 1990, 26(1):17-21. doi: 10.1111/j.1440-1754.1990.tb02372.x.
doi: 10.1111/j.1440-1754.1990.tb02372.x.
|
[16] |
Crapper L, Ernst C. Comparative analysis of self-injury in people with psychopathology or neurodevelopmental disorders[J]. Pediatr Clin North Am, 2015, 62(3):619-631. doi: 10.1016/j.pcl.2015.03.001.
doi: 10.1016/j.pcl.2015.03.001
|
[17] |
Schwartz L, Caixàs A, Dimitropoulos A, et al. Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium[J]. J Neurodev Disord, 2021, 13(1):25. doi: 10.1186/s11689-021-09373-2.
doi: 10.1186/s11689-021-09373-2
pmid: 34148559
|
[18] |
郜珊珊, 代鹏, 赵干业, 等. 两例Prader-Willi综合征患儿的临床特征及致病基因分析[J]. 中华肥胖与代谢病电子杂志, 2021, 7(3):203-206. doi: 10.3877/cma.j.issn.2095-9605.2021.03.012.
doi: 10.3877/cma.j.issn.2095-9605.2021.03.012
|
[19] |
Peron A, Canevini MP, Ghelma F, et al. Phenotypes in adult patients with Rett syndrome: results of a 13-year experience and insights into healthcare transition[J]. J Med Genet, 2022, 59(1):39-45. doi: 10.1136/jmedgenet-2020-107333.
doi: 10.1136/jmedgenet-2020-107333
|
[20] |
Selicorni A, Mariani M, Lettieri A, et al. Cornelia de Lange Syndrome: From a Disease to a Broader Spectrum[J]. Genes (Basel), 2021, 12(7):1075. doi: 10.3390/genes12071075.
doi: 10.3390/genes12071075
|
[21] |
Kim KJ, Yamada Y, Suzumori K, et al. Molecular analysis of hypoxanthine guanine phosphoribosyltransferase (HPRT) gene in five Korean families with Lesch-Nyhan syndrome[J]. J Korean Med Sci, 1997, 12(4):332-339. doi: 10.3346/jkms.1997.12.4.332.
doi: 10.3346/jkms.1997.12.4.332
pmid: 9288634
|
[22] |
Veeramachaneni V. Data Analysis in Rare Disease Diagnostics[J]. J Indian Inst Sci, 2020, 100(4):733-751. doi: 10.1007/s41745-020-00189-y.
doi: 10.1007/s41745-020-00189-y
|
[23] |
Li X, Liu M, Lin J, et al. A questionnaire-based study to comprehensively assess the status quo of rare disease patients and care-givers in China[J]. Orphanet J Rare Dis, 2021, 16(1):327. doi: 10.1186/s13023-021-01954-7.
doi: 10.1186/s13023-021-01954-7
|